Conference Reports

ESCMID Conference on Corona Virus Disease (ECCVID)

virtual
23 September 2020 - 25 September 2020

European Respiratory Society (ERS) International Congress 2020

Vienna
05 September 2020 - 09 September 2020

American Thoracic Society (ATS) 2020 Virtual

05 August 2020 - 10 August 2020

European Respiratory Society (ERS) International Congress 2019

Madrid
28 September 2019 - 02 October 2019

American Thoracic Society 2019 (ATS 2019) International Conference

Dallas, Texas, US
17 May 2019 - 22 May 2019

European Lung Cancer Congress 2019 (ELCC 2019)

Geneva, Switzerland
10 April 2019 - 13 April 2019

American Thoracic Society International Conference 2018 (ATS 2018)

San Diego, California, US
18 May 2018 - 23 May 2018

European Lung Cancer Congress (ELCC) 2018

Geneva
11 April 2018 - 14 April 2018

Congress of Asian Pacific Society of Respirology (APSR 2017)

Sydney
23 November 2017 - 26 November 2017
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 22 Sep 2020

Treatment with the DPP 1* inhibitor brensocatib prolonged time to exacerbation and reduced exacerbation rates in patients with non-cystic fibrosis bronchiectasis, according to the phase II WILLOW** study presented at ERS 2020.

Pearl Toh, 28 Sep 2020
With much remains controversial regarding the possible transmission route of SARS-CoV-2 virus, a study reveals yet another surprise worthy of caution in the hospital setting.
Audrey Abella, 22 Sep 2020
The first-in-class oral tyrosine kinase inhibitor (TKI) masitinib demonstrated a positive benefit-risk profile over a sustained period in patients with severe persistent asthma regardless of baseline eosinophil level, with the greatest benefit seen among those with the highest oral corticosteroid (OCS) dependency, according to data presented at ERS 2020.